AZD7442 – a potential combination therapy for the prevention and treatment of COVID-19

Trial Identifier:	D8850C00001
Sponsor:	AstraZeneca
Collaborator:	Parexel International
NCTID::	NCT04507256
Start Date:	August 2020
Primary Completion Date:	October 2021
Study Completion Date:	October 2021
Condition:	COVID-19 Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Harrow, United Kingdom, HA1 3UJ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.